MGZ 0.00% 2.0¢ medigard limited

Production numbers

  1. 7,518 Posts.
    lightbulb Created with Sketch. 847
    "The manufacturing facility in Suzhou will be capable of producing between 300,000 and 500,000 units of BCDs monthly during the first 6 months with production expanding to 5 million units per month"

    And this was from 2010, just as a rough indicator of the future potential:

    "⎯ Potential to deliver to Medigard up to USD 15c per device sold
    ⎯ Minimum 70 million units for the Blood Collection Device over the five‐year term of initial agreement.
    ⎯ US market consumes 700m Blood Collection Devices per year
    ⎯ Agreements could conservatively deliver revenues to Medigard across all products of up to $40m per
    annum within 5 years"
 
watchlist Created with Sketch. Add MGZ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.